Document and Entity Information
Document and Entity Information | Dec. 22, 2023 |
Cover [Abstract] | |
Security Exchange Name | NASDAQ |
Amendment Flag | false |
Entity Central Index Key | 0001811764 |
Current Fiscal Year End Date | --12-31 |
Document Type | 8-K |
Document Period End Date | Dec. 22, 2023 |
Entity Registrant Name | POINT BIOPHARMA GLOBAL INC. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-39373 |
Entity Tax Identification Number | 85-0800493 |
Entity Address, Address Line One | 4850 West 78th Street |
Entity Address, City or Town | Indianapolis |
Entity Address, State or Province | IN |
Entity Address, Postal Zip Code | 46268 |
City Area Code | 317 |
Local Phone Number | 543-9957 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, $0.0001 Par Value Per Share |
Trading Symbol | PNT |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |